Neringer 1992.

Methods	Randomised, double‐blind Multicentre study: 21 Swedish centres
Participants	Number: 703 women enrolled Age: 17‐75 years Inclusion criteria: UAC GROUP 1 196 women GROUP 2 196 women GROUP 3 195 women
Interventions	GROUP 1 3 days lomefloxacin (400 mg once daily) GROUP 2 7 days lomefloxacin (400 mg once daily) GROUP 3 7 days norfloxacin (400 mg twice daily)
Outcomes	Bacteriological and clinical response Adverse events SAEs Events causing withdrawal
Notes	Compared group 1 and 3
Risk of bias
Bias	Authors' judgement	Support for judgement
Allocation concealment?	Low risk	A ‐ Adequate